Fact CheckerSign in

NCT05504356Recruiting

Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation

Source: ClinicalTrials.gov · Last updated 5 Oct 2026

Brief summary (registry, in English)

VIBRANT-AF seeks to: * Identify clinically relevant predictors of effectiveness and complications of AF ablation procedures in a prospective, US-based, multi-center, real-world longitudinal study * Assess changes in modifiable lifestyle-related exposures influence the effectiveness of AF ablation * Determine incidence and predictors of complications of AF ablation procedures Participants will connect with the Eureka Research Platform and answer a series of surveys and activities over a one-year period. They will be asked about lifestyle habits, recurrence of AFib, hospitalizations, and general feelings and emotions.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1125 (estimated)
First submitted
15 Aug 2022
Start date
Apr 2022
Primary completion date
Oct 2026
Lead sponsor
University of California, San Francisco
NCT number
NCT05504356

What you commit to

  • Study type: Observational
  • Planned participants: 1125
  • From Apr 2022 to the primary completion date, Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Unable to consent for themselves
  • Unable to read, speak, comprehend English

Who the study is looking for

  • Adults age 18 and older
  • Must have a smartphone device (iOS and/or Android) and cell phone number to participate on the mobile app, and will be willing to download the Eureka Research Platform mobile application
  • Must have email address to participate on the web portal (accessible on any web-connected device)
  • Undergone a catheter ablation procedure for atrial fibrillation in the week prior to recruitment, or have an ablation planned for within a week from recruitment

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California San Francisco
Coordinator of this site? Confirm its status
San FranciscoUnited StatesRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.